Partner at Vesalius Biocapital
Check size: Vesalius Biocapital does not publish a standard current check-size range on its official site.
Guy Geldhof invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical devices and digital health with active strategic support.
Present the science, validation, intellectual property, clinical need, regulatory path, market and financing milestones.
Experienced teams translating differentiated science or health technology into products with clear clinical and commercial value.
Opportunities outside life sciences and healthcare, or without credible scientific and development evidence, are less aligned.